創傷治療用生物製剤のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)

【英語タイトル】Europe Wound Care Biologics Market : Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Data Bridge Market Researchが出版した調査資料(DBMR810543)・商品コード:DBMR810543
・発行会社(調査会社):Data Bridge Market Research
・発行日:2018年8月
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:ヨーロッパ
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(印刷不可、Web Access)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Corporate UserUSD3,200 ⇒換算¥361,600見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Data Bridgeが出版した本調査レポートでは、創傷治療用生物製剤のヨーロッパ市場について調査・分析し、創傷治療用生物製剤のヨーロッパ市場動向、市場予測、セグメント別分析、創傷治療用生物製剤市場規模、関連企業分析などを含め以下の構成でお届けいたします。
【レポートの概要】

Europe wound care biologics market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Prominent factors driving the growth of this market consist of increasing incidence of foot ulcers, increasing incidence of burn cases, rising number of geriatric population, innovation in wound care biologics are fuel the growth of wound care biologics market.

The key market players for Europe wound care biologics market are listed below:

• MiMedx
• Organogenesis Inc.
• Mölnlycke Health Care AB
• Integra Life Sciences
• ConvaTec Inc.
• BioHorizons IPH, Inc.
• Anika Therapeutics, Inc.
• Osiris Therapeutics, Inc.
• Vericel Corporation
• WRIGHT MEDICAL GROUP N.V.

The Europe wound care biologics market is segmented into:
• Product Type
• Wound Type
• End User

On the basis of product type the Europe wound care biologics market is segmented into synthetic skin grafts segment, growth factors segment, allografts segment, xenografts segment. In 2018, synthetic skin grafts segment isexpected to dominate the Europe wound care biologics market with highest market shares. However, allografts segment isexpected to grow at the highest CAGR in the forecast period. Growth factors segment is further sub segmented into platelet-derived growth factor (PDGF) segment, platelet rich plasma (PRP) segment, epidermal growth factor (EGF) segment and basic fibroblast growth factor (BFGF) segment, granulocyte colony stimulating factor (G-CSF) segment, talactoferrin alfa segment, thrombin peptide (TP508) segment, keratinocyte growth factor (KGF) segment.
On the basis of wound type the Europe wound care biologics market is categorized into wounds, and ulcers, burns. In 2018, wounds segment is expected to dominate the Europe wound care biologics market with the highest market shares. However, ulcers segment is expected to grow at the highest CAGR in the forecast period.
On the basis of end user Europe wound care biologics market is segmented into hospitals, wound care centres and ambulatory centers, clinics, community healthcare centers. In 2018, hospitals segment is expected to dominate the Europe wound care biologics market with the highest CAGR in the forecast period 2018 to 2025.
Based on geography, the market is segmented into:
• Germany
• France
• U.K.
• Spain
• Italy
• Switzerland
• Netherlands
• Russia
• Turkey
• Belgium
• Rest of Europe
Covered in this report
The report covers the present scenario and the growth prospects of the Europe wound care biologics market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table Of Contents
1 Introduction 30
1.1 Objectives Of The Study 30
1.2 Market Definition 30
1.3 Overview Of Europe Wound Care Biologics Market 30
1.4 Currency And Pricing 31
1.5 Limitation 31
1.6 Markets Covered 32
2 Market Segmentation 34
2.1 Markets Covered 34
2.2 Geographic Scope 35
2.3 Years Considered For The Study 36
2.4 Currency And Pricing 36
2.5 Research Methodology 37
2.6 Primary Interviews With Key Opinion Leaders 40
2.1 Dbmr Market Position Grid 41
2.2 Dbmr Market Challenge Matrix 42
2.3 Secondary Sources 43
2.4 Assumptions 43
3 Market Overview 44
3.1 Drivers 46
3.1.1 Increasing Cases Of Diabetic Foot Ulcers 46
3.1.2 Increasing Incidences Of Burn Cases 46
3.1.3 Rising Number Of Geriatric Population 47
3.1.4 Innovation In Wound Care Biologics 48
3.1.5 New Product Launches 50
3.2 Restrains 50
3.2.1 High Cost Of Wound Treatment And Wound Care Biologics 50
3.2.2 Risk Of Skin Substitue Failure 51
3.3 Opportunities 52
3.3.1 3D Skin Printing 52
3.3.2 Awareness Programs 53
3.4 Challenges 54
3.4.1 Lack Of Wound Management Services 54
4 Executive Summary 55
5 Premium Insights 58
6 Europe Wound Care Biologics Market, By Product Type 63
6.1 Overview 64
6.2 Synthetic Skin Grafts 66
6.3 Growth Factors 67
6.3.1 Platelet Derived Growth Factor (Pdgf) 70
6.3.2 Platelet Rich Plasma (Prp) 70
6.3.3 Epidermal Growth Factors (Egf) 70
6.3.4 Basic Fibroblast Growth Factors (Bfgf) 71
6.3.5 Granulocyte Colony Stimulating Factor (G-Csf) 71
6.3.6 Talactoferrin Alfa 71
6.3.7 Thrombin Peptide 72
6.3.8 Keratinocy Growth Factor (Kgf) 72
6.4 Allografts 73
6.5 Xenografts 74
7 Europe Wound Care Biologics Market, By Wound Type 76
7.1 Overview 77
7.2 Wounds 78
7.2.1 Surgical Wound 80
7.2.1.1 Skin Surgery 81
7.2.1.1.1 Wound Closure 82
7.2.1.1.2 Skin Biopsy 82
7.2.1.1.3 Skin Flap 82
7.2.1.1.4 Skin Graft 82
7.2.1.1.5 Others 82
7.2.1.2 Cosmetic Procedure 83
7.2.1.2.1 Brest Enhancement 84
7.2.1.2.2 Facial Contouring 85
7.2.1.2.3 Facial Rejuvenation: 85
7.2.1.2.4 Body Contouring 85
7.2.1.2.5 Skin Rejuvenation 85
7.2.1.2.6 Others 86
7.2.1.3 Gynecologic Procedures 86
7.2.1.3.1 Pubovaginalis Sling 86
7.2.1.3.2 Pelvic Floor Reconstruction 87
7.2.1.3.3 Rectocele Repair Surgery 87
7.2.1.3.4 Others 87
7.2.1.4 Gastrointestinal Procedure 87
7.2.1.4.1 General Gastrointestinal Surgery 88
7.2.1.4.2 Hernia 89
7.2.1.4.3 Others 89
7.2.2 Acute Wounds 90
7.2.3 Chronic Wounds 90
7.2.4 Traumatic Wounds 91
7.3 Burns 91
7.3.1 Ulcers 92
7.3.2 Diabetic Ulcers 94
7.3.3 Pressure Ulcer 94
7.3.4 Venous Ulcer 95
7.3.5 Others 95
8 Europe Wound Care Biologics Market, By End User 96
8.1 Overview 97
8.2 Hospitals 99
8.3 Wound Care Centers 100
8.4 Ambulatory Surgical Centers 101
8.5 Clinics 103
8.6 Community Healthcare Center 104
9 Europe Wound Care Biologics Market: Geography 105
9.1 Europe 105
9.1.1 Germany 117
9.1.2 France 124
9.1.3 U.K. 131
9.1.4 Italy 138
9.1.5 Switzerland 145
9.1.6 Netherlands 152
9.1.7 Russia 160
9.1.8 Turkey 167
9.1.9 Spain 174
9.1.10 Belgium 181
9.1.11 Rest Of Europe 188
10 Europe Wound Care Biologics Market, Company Landscape 189
10.1 Company Share Analysis: Europe 189
11 Company Profile 190
11.1 Mimedx. 190
11.1.1 Company Overview 190
11.1.2 Revenue Analysis: 190
11.1.3 Company Share Analysis: 191
11.1.4 Product Portfolio 191
11.1.5 Recent Developments 192
11.2 Organogenesis Inc 193
11.2.1 Company Overview 193
11.2.2 Geographic Presence 193
11.2.3 Company Share Analysis: 194
11.2.4 Product Portfolio 194
11.2.5 Recent Developments 195
11.3 Integra Lifesciences 196
11.3.1 Company Overview 196
11.3.2 Revenue Analysis 196
11.3.3 Company Share Analysis: 197
11.3.4 Product Portfolio 197
11.3.5 Recent Developments 198
11.4 Convatec Inc. 199
11.4.1 Company Overview 199
11.4.2 Revenue Analysis 199
11.4.3 Company Share Analysis: 200
11.4.4 Product Portfolio : 200
11.4.5 Recent Developments 200
11.5 Acell Inc. 201
11.5.1 Company Overview 201
11.5.2 Product Portfolio 201
11.5.3 Recent Developments 202
11.6 Allosource 203
11.6.1 Company Overview 203
11.6.2 Product Portfolio 203
11.6.3 Recent Developments 204
11.7 Alphatec Spine, Inc. ( A Subsidary Of Alphatec Holdings, Inc) 205
11.7.1 Company Overview 205
11.7.2 Product Portfolio 205
11.7.3 Recent Developments 205
11.8 Amnio Technology, Llc 206
11.8.1 Company Overview 206
11.8.2 Product Portfolio 206
11.8.3 Recent Developments 207
11.9 Amniox Medical, Inc. 208
11.9.1 Company Overview 208
11.9.2 Product Portfolio 208
11.9.3 Recent Developments 209
11.10 Anika Therapeutics, Inc. 210
11.10.1 Company Overview 210
11.10.2 Revenue Analysis 210
11.10.3 Product Portfolio 211
11.10.4 Recent Developments 211
11.11 Biohorizons Iph, Inc ( A Subsidary Of Henry Schein, Inc.) 212
11.11.1 Company Overview 212
11.11.2 Geographicpresence 212
11.11.3 Product Portfolio 213
11.11.4 Recent Developments 213
11.12 Kerecis 214
11.12.1 Company Overview 214
11.12.2 Geographical Presence 214
11.12.3 Product Portfolio 215
11.12.4 Recent Developments 215
11.13 Marine Polymer Technologies, Inc 216
11.13.1 Company Overview 216
11.13.2 Product Portfolio 216
11.13.3 Recent Developments 216
11.14 Mölnlycke Health Care Ab 217
11.14.1 Company Overview 217
11.14.2 Revenue Analysis 217
11.14.3 Product Portfolio 218
11.14.4 Recent Developments 218
11.15 Osiris Therapeutics, Inc. 219
11.15.1 Company Overview 219
11.15.2 Revenue Analysis 219
11.15.3 Product Portfolio 220
11.15.4 Recent Developments 220
11.16 Skye Biologics Inc. 221
11.16.1 Company Overview 221
11.16.2 Product Portfolio : 221
11.16.3 Recent Development: 222
11.17 Smith And Nephew 223
11.17.1 Company Overview 223
11.17.2 Revenue Analysis 223
11.17.3 Product Portfolio 224
11.17.4 Recent Developments 224
11.18 Solsys Medical. 225
11.18.1 Company Overview 225
11.18.2 Product Portfolio 226
11.18.3 Recent Developments 226
11.19 Vericel Corporation. 227
11.19.1 Company Overview 227
11.19.2 1.1.2 Revenue Analysis 227
11.19.3 Product Portfolio 228
11.19.4 Recent Developments 228
11.20 Wright Medical Group N.V 229
11.20.1 Company Overview 229
11.20.2 1.1.2 Revenue Analysis 229
11.20.3 Product Portfolio 230
11.20.4 Recent Developments 231
12 Related Reports 232

List Of Tables
Table 1 Europe Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 55
Table 2 Europe Synthetic Skin Grafts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 56
Table 3 Europe Growth Factors In Wound Care Biologics Market, By Product Type, 2016– 2025 (Usd Million) 58
Table 4 Europe Growth Factors In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 59
Table 5 Europe Allografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 63
Table 6 Europe Xenografts In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 65
Table 7 Europe Wound Care Biologics Market, By Wound Type, 2015– 2025 (Usd Million) 68
Table 8 Europe Wounds In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 69
Table 9 Europe Wounds In Wound Care Biologics Market, By Wound Type, 2016– 2025 (Usd Million) 69
Table 10 Europe Surgical Wound In Wound Care Biologics Market, 2016-2025 (Usd Million) 70
Table 11 Europe Skin Surgery In Wound Care Biologics Market, 2016-2025 (Usd Million) 71
Table 12 Number Of Cosmetic Surgery, 2016 & 2017 73
Table 13 Europe Cosmetic Surgery In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 74
Table 14 Europe Gynecologic Procedures In Wound Care Biologics Market, By Wound Type, 2016-2025 (Usd Million) 76
Table 15 Europe Gastrointestinal Procedures In Wound Care Biologics Market, By Wound Type 2018-2025 (Usd Million) 78
Table 16 Europe Burns In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 82
Table 17 Europe Ulcers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 83
Table 18 Europe Ulcers In Wound Care Biologics Market, By Wound Type 2016-2025 (Usd Million) 83
Table 19 Europe Wound Care Biologics Market, By End User, 2016 – 2025 (Usd Million) 88
Table 20 Europe Hospitals In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 89
Table 21 Europe Wound Care Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 90
Table 22 Statistics For Ambulatory Surgical Center. U.S. 91
Table 23 Europe Ambulatory Surgical Centers In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 92
Table 24 Europe Clinics In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 93
Table 25 Europe Community Healthcare Center In Wound Care Biologics Market, By Region, 2016– 2025 (Usd Million) 94
Table 26 Europe Wound Care Biologics Market, By Country, Usd Million (2016-2025) 100
Table 27 Europe Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101
Table 28 Europe Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 101
Table 29 Europe Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102
Table 30 Europe Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 102
Table 31 Europe Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103
Table 32 Europe Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 103
Table 33 Europe Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 34 Europe Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 104
Table 35 Europe Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 36 Europe Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 105
Table 37 Europe Wound Care Biologics, By End User, 2016-2025, (Usd Million) 106
Table 38 Germany Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 107
Table 39 Germany Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 108
Table 40 Germany Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 108
Table 41 Germany Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109
Table 42 Germany Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 109
Table 43 Germany Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 110
Table 44 Germany Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111
Table 45 Germany Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 111
Table 46 Germany Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 47 Germany Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 112
Table 48 Germany Wound Care Biologics, By End User, 2016-2025, (Usd Million) 113
Table 49 France Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 114
Table 50 France Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 115
Table 51 France Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 115
Table 52 France Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116
Table 53 France Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 116
Table 54 France Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 117
Table 55 France Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118
Table 56 France Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 118
Table 57 France Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 58 France Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 119
Table 59 France Wound Care Biologics, By End User, 2016-2025, (Usd Million) 120
Table 60 U.K. Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 121
Table 61 U.K. Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 122
Table 62 U.K. Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 122
Table 63 U.K. Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123
Table 64 U.K. Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 123
Table 65 U.K. Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 124
Table 66 U.K. Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125
Table 67 U.K. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 125
Table 68 U.K. Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126
Table 69 U.K. Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 126
Table 70 U.K. Wound Care Biologics, By End User, 2016-2025, (Usd Million) 127
Table 71 Italy Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 128
Table 72 Italy Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 129
Table 73 Italy Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 129
Table 74 Italy Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 130
Table 75 Italy Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 131
Table 76 Italy Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 131
Table 77 Italy Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132
Table 78 Italy Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 132
Table 79 Italy Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133
Table 80 Italy Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 133
Table 81 Italy Wound Care Biologics, By End User, 2016-2025, (Usd Million) 134
Table 82 Switzerland Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 135
Table 83 Switzerland Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 136
Table 84 Switzerland Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 136
Table 85 Switzerland Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137
Table 86 Switzerland Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 137
Table 87 Switzerland Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 138
Table 88 Switzerland Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139
Table 89 Switzerland Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 139
Table 90 Switzerland Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140
Table 91 Switzerland Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 140
Table 92 Switzerland Wound Care Biologics, By End User, 2016-2025, (Usd Million) 141
Table 93 Netherlands Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 142
Table 94 Netherlands Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 143
Table 95 Netherlands Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144
Table 96 Netherlands Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 144
Table 97 Netherlands Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 145
Table 98 Netherlands Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 145
Table 99 Netherlands Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 146
Table 100 Netherlands Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147
Table 101 Netherlands Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 147
Table 102 Netherlands Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 148
Table 103 Switzerland Wound Care Biologics, By End User, 2016-2025, (Usd Million) 149
Table 104 Russia Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 150
Table 105 Russia Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 151
Table 106 Russia Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 152
Table 107 Russia Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153
Table 108 Russia Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 153
Table 109 Russia Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154
Table 110 Russia Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 154
Table 111 Russia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 155
Table 112 Russia Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 155
Table 113 Russia Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 156
Table 114 Russia Wound Care Biologics, By End User, 2016-2025, (Usd Million) 156
Table 115 Turkey Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 157
Table 116 Turkey Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 158
Table 117 Turkey Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 159
Table 118 Turkey Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 159
Table 119 Turkey Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160
Table 120 Turkey Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 160
Table 121 Turkey Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161
Table 122 Turkey Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 161
Table 123 Turkey Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 162
Table 124 Turkey Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 162
Table 125 Turkey Wound Care Biologics, By End User, 2016-2025, (Usd Million) 163
Table 126 Spain Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 164
Table 127 Spain Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 165
Table 128 Spain Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 165
Table 129 Spain Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 166
Table 130 Spain Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 166
Table 131 Spain Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 167
Table 132 Spain Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168
Table 133 Spain Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 168
Table 134 Spain Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 169
Table 135 Spain Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 169
Table 136 Spain Wound Care Biologics, By End User, 2016-2025, (Usd Million) 170
Table 137 Belgium Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 171
Table 138 Belgium Growth Factors In Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 172
Table 139 Belgium Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 172
Table 140 Belgium Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 173
Table 141 Belgium Surgical Wounds In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 173
Table 142 Belgium Skin Surgery In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 174
Table 143 Belgium Cosmetic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175
Table 144 Belgium Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 175
Table 145 Belgium Gynecologic Procedures In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 176
Table 146 Belgium Ulcers In Wound Care Biologics, By Wound Type, 2016-2025, (Usd Million) 176
Table 147 Belgium Wound Care Biologics, By End User, 2016-2025, (Usd Million) 177
Table 148 Rest Of Europe Wound Care Biologics, By Product Type, 2016-2025, (Usd Million) 178




【レポートのキーワード】

創傷治療用生物製剤

★調査レポート[創傷治療用生物製剤のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)] (コード:DBMR810543)販売に関する免責事項を必ずご確認ください。
★調査レポート[創傷治療用生物製剤のヨーロッパ市場:企業概要・規模・シェア・成長・動向・予測(~2025年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆